Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy with Nephrotic Syndrome

Abroad (travel likely)RecruitingPHASE3

Conditions

Glomerulonephritis, Membranous · Nephrotic Syndrome,Idiopathic

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Shoichi Shoichi, PhD, MD

    Principal Investigator

    Nagoya University Hospital